ABBOTT LABORATORIES
ABT · Pharmaceutical Preparations · 1.74B shares · -0%/yr ↓ buyback · EDGAR filings ↗
Net buyback after stock comp: $583M (gross $1.2B, SBC $644M)
Reference price $86.82 · est. market cap ~$151.2B — last insider purchase, 2026-05-07 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
A88Diversified healthcare giant with strong margins, elite FCF, and a clean balance sheet.
Strengths
- Elite free cash flow — FCF $7.4B (98th), FCF margin 17%
- Strong margins/returns — operating margin 18% (88th), ROA 8% (91st)
- Low leverage — D/E 0.2
Risks
- Earnings comp — net income -51% vs prior-year one-off
- Device/diagnostics pricing competition — per 10-K
- FX/EM exposure — per 10-K
Notable findings
- High convictionHigh conviction — notable institutional holders, insider buying, and a strong balance sheet
- Exec changeRecent 8-K item 5.02 8-K ↗
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- FDA recallFDA recall (Class II) — Alinity ci-series System Control Module (SCM), REF: 03R70-01, 03R70-20 (2025-11-13)
- Insider buyingInsider buying — 6 open-market buy(s) by 4 insider(s) (cluster of 4 insiders, ~$4M, last 6mo) Form 4 ↗
- FDA approvalFDA clearance/approval — ARCHITECT Total PSA / Alinity i Total PSA (LN 6C06/07P92) (2026-02-23)
- Strong balance sheetStrong balance sheet — $9.9B cash & investments
- Insider sellingInsider selling — 6 open-market sale(s) by 6 insider(s) (cluster of 6 insiders, ~$485,320, last 6mo) Form 4 ↗
- Notable holderHeld by 6 notable fund(s): STATE STREET CORP, GOLDMAN SACHS GROUP INC, FMR LLC +3 more (as of 2026-03-31)
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
56.4%
Operating margin
18.2%
Net margin
14.7%
Return on equity
12.5%
Return on assets
7.5%
ROIC
10.3%
Revenue growth (QoQ)
-2.6%
Net-income growth
-51.3%
Debt / equity
0.2×
Current ratio
1.6×
Free cash flow
$7.4B
Tangible book value
$22.6B
Cash & investments
$9.9B
Stock comp / revenue
1.5%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-07 | Stratton John G | Buy | 2.0K | $86.82 |
| 2026-04-28 | Moreland Mary K | I | 5.3K | $94.41 |
| 2026-04-27 | STARKS DANIEL J | Buy | 10K | $92.65 |
| 2026-04-24 | McDew Darren W | Grant | 2.3K | — |
| 2026-04-24 | Babineaux-Fontenot Claire | Grant | 2.3K | — |
| 2026-04-24 | Kumbier Michelle | Grant | 2.3K | — |
| 2026-04-24 | Roman Michael F | Grant | 2.3K | — |
| 2026-04-24 | Blount Sally E. | Grant | 2.3K | — |
| 2026-04-24 | Stratton John G | Grant | 2.3K | — |
| 2026-04-24 | Conroy Kevin T | Grant | 2.3K | — |
| 2026-04-24 | McKinstry Nancy | Grant | 2.3K | — |
| 2026-04-24 | STARKS DANIEL J | Grant | 2.3K | — |
| 2026-04-24 | O'Grady Michael | Grant | 2.3K | — |
| 2026-04-24 | Ahuja Nita | Grant | 2.3K | — |
| 2026-04-24 | Gonzalez Patricia Paola | Grant | 2.3K | — |
| 2026-04-23 | Boudreau Philip P | I | 8.9K | $92.04 |
| 2026-04-23 | Boudreau Philip P | Buy | 2.2K | $91.50 |
| 2026-03-23 | ORVILLE JACOB A | Grant | 13K | — |
| 2026-03-02 | Cushman Elizabeth C. | Sell | 263 | $115.58 |
| 2026-03-02 | Shroff Eric | Sell | 709 | $115.58 |
| 2026-03-02 | Morrone Louis H. | Sell | 1.1K | $115.58 |
| 2026-03-02 | Moreland Mary K | Sell | 613 | $115.58 |
| 2026-03-02 | MCCOY JOHN A. JR. | Sell | 585 | $115.58 |
| 2026-03-02 | Salvadori Daniel Gesua Sive | Sell | 885 | $115.58 |
| 2026-02-27 | Moreland Mary K | Tax withheld | 4.6K | $116.26 |
| 2026-02-27 | Morrone Louis H. | Tax withheld | 4.0K | $116.26 |
| 2026-02-27 | Scoggins Christopher J | Tax withheld | 5.0K | $116.26 |
| 2026-02-27 | Boudreau Philip P | Tax withheld | 7.4K | $116.26 |
| 2026-02-27 | MCCOY JOHN A. JR. | Tax withheld | 1.1K | $116.26 |
| 2026-02-27 | Shroff Eric | Tax withheld | 1.4K | $116.26 |
| 2026-02-27 | Salvadori Daniel Gesua Sive | Tax withheld | 6.6K | $116.26 |
| 2026-02-27 | Cushman Elizabeth C. | Tax withheld | 1.4K | $116.26 |
| 2026-02-27 | Ford Robert B | Tax withheld | 30K | $116.26 |
| 2026-02-27 | Earnhardt Lisa D | Tax withheld | 8.6K | $116.26 |
| 2026-02-24 | Boudreau Philip P | Grant | 28K | — |
| 2026-02-24 | Cushman Elizabeth C. | Grant | 15K | — |
| 2026-02-24 | Shroff Eric | Grant | 11K | — |
| 2026-02-24 | Morrone Louis H. | Grant | 15K | — |
| 2026-02-24 | Moreland Mary K | Grant | 14K | — |
| 2026-02-24 | Scoggins Christopher J | Grant | 19K | — |
| 2026-02-24 | MCCOY JOHN A. JR. | Grant | 5.4K | — |
| 2026-02-24 | Salvadori Daniel Gesua Sive | Grant | 22K | — |
| 2026-02-24 | Ford Robert B | Grant | 83K | — |
| 2026-02-24 | Earnhardt Lisa D | Grant | 27K | — |
| 2026-02-04 | STARKS DANIEL J | Buy | 5.0K | $108.33 |
| 2026-02-04 | STARKS DANIEL J | Buy | 5.0K | $109.14 |
| 2026-01-23 | Ford Robert B | Buy | 19K | $107.13 |
| 2025-12-11 | Salvadori Daniel Gesua Sive | Gift | 1.5K | $123.28 |
| 2025-11-25 | Shroff Eric | Sell | 1.6K | $128.02 |
| 2025-09-01 | MCCOY JOHN A. JR. | Tax withheld | 79 | $132.66 |
| 2025-09-01 | Boudreau Philip P | Tax withheld | 387 | $132.66 |
| 2025-08-08 | Boudreau Philip P | Sell | 5.5K | $134.55 |
| 2025-06-30 | Morrone Louis H. | Tax withheld | 269 | $134.38 |
| 2025-06-27 | Cushman Elizabeth C. | Grant | 3.8K | — |
| 2025-04-30 | Blount Sally E. | Sell | 2.6K | $129.66 |
| 2025-04-25 | Roman Michael F | Grant | 1.6K | — |
| 2025-04-25 | O'Grady Michael | Grant | 1.6K | — |
| 2025-04-25 | McKinstry Nancy | Grant | 1.6K | — |
| 2025-04-25 | McDew Darren W | Grant | 1.6K | — |
| 2025-04-25 | Gonzalez Patricia Paola | Grant | 1.6K | — |
| 2025-04-25 | Blount Sally E. | Grant | 1.6K | — |
| 2025-04-25 | Babineaux-Fontenot Claire | Grant | 1.6K | — |
| 2025-04-25 | Alpern Robert J | Grant | 1.6K | — |
| 2025-04-25 | Kumbier Michelle | Grant | 1.6K | — |
| 2025-04-25 | Stratton John G | Grant | 1.6K | — |
| 2025-04-25 | STARKS DANIEL J | Grant | 1.6K | — |
| 2025-03-07 | Earnhardt Lisa D | Option exercise | 200 | $80.98 |
| 2025-03-07 | Earnhardt Lisa D | Sell | 200 | $136.65 |
| 2025-03-06 | Earnhardt Lisa D | Option exercise | 91K | $80.98 |
| 2025-03-06 | Earnhardt Lisa D | Sell | 91K | $133.82 |
| 2025-03-03 | Wainer Andrea F | Sell | 949 | $138.17 |
| 2025-03-03 | Shroff Eric | Sell | 562 | $138.17 |
| 2025-03-03 | Morrone Louis H. | Sell | 1.1K | $138.17 |
| 2025-03-03 | Moreland Mary K | Sell | 791 | $138.17 |
| 2025-03-03 | MCCOY JOHN A. JR. | Sell | 562 | $138.17 |
| 2025-02-28 | Moreland Mary K | Tax withheld | 5.6K | $135.87 |
| 2025-02-28 | Morrone Louis H. | Tax withheld | 4.4K | $135.87 |
| 2025-02-28 | MCCOY JOHN A. JR. | Tax withheld | 1.1K | $135.87 |
| 2025-02-28 | Salvadori Daniel Gesua Sive | Tax withheld | 8.5K | $135.87 |
| 2025-02-28 | Wainer Andrea F | Tax withheld | 7.3K | $135.87 |
| 2025-02-28 | Ford Robert B | Tax withheld | 32K | $135.87 |
| 2025-02-28 | Earnhardt Lisa D | Tax withheld | 8.3K | $135.87 |
| 2025-02-28 | Boudreau Philip P | Tax withheld | 4.9K | $135.87 |
| 2025-02-28 | ALLEN HUBERT L | Tax withheld | 8.4K | $135.87 |
| 2025-02-25 | MCCOY JOHN A. JR. | Grant | 4.0K | — |
| 2025-02-25 | Wainer Andrea F | Grant | 12K | — |
| 2025-02-25 | Salvadori Daniel Gesua Sive | Grant | 17K | — |
| 2025-02-25 | Morrone Louis H. | Grant | 10K | — |
| 2025-02-25 | Moreland Mary K | Grant | 11K | — |
| 2025-02-25 | Ford Robert B | Grant | 65K | — |
| 2025-02-25 | Earnhardt Lisa D | Grant | 19K | — |
| 2025-02-25 | Boudreau Philip P | Grant | 22K | — |
| 2025-02-25 | ALLEN HUBERT L | Grant | 15K | — |
| 2025-02-05 | Ford Robert B | Option exercise | 285K | $38.40 |
| 2025-02-05 | Ford Robert B | Sell | 285K | $131.17 |
| 2025-01-30 | Salvadori Daniel Gesua Sive | Sell | 24K | $128.50 |
| 2025-01-30 | ALLEN HUBERT L | Option exercise | 58K | $38.40 |
| 2025-01-30 | Salvadori Daniel Gesua Sive | Option exercise | 24K | $38.40 |
| 2025-01-30 | ALLEN HUBERT L | Sell | 58K | $128.07 |
| 2025-01-29 | ALLEN HUBERT L | Sell | 131K | $128.35 |
| 2025-01-29 | ALLEN HUBERT L | Option exercise | 131K | $38.40 |
| 2025-01-28 | Morrone Louis H. | Sell | 2.6K | $127.39 |
All non-derivative Form 4 activity (SEC), newest first.
Supply chain
Customers (0)
Suppliers (1)
Named in the 10-K; linked when we track them.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-04-27 | Exec/director change5.03Shareholder voteExhibits | filing ↗ |
| 2026-04-17 | OtherExhibits | filing ↗ |
| 2026-04-16 | ResultsExhibits | filing ↗ |
| 2026-03-23 | OtherExhibits | filing ↗ |
| 2026-03-09 | Material agreementDebt obligationExhibits | filing ↗ |
| 2026-02-26 | Material agreementExhibits | filing ↗ |
| 2026-02-20 | 5.03Exhibits | filing ↗ |
| 2026-01-22 | ResultsExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 10-Q | 2026-04-29 | 2026-03-31 | 0001628280-26-028357 ↗ |
| 8-K | 2026-04-27 | 2026-04-24 | 0001104659-26-049434 ↗ |
| 8-K | 2026-04-17 | 2026-04-10 | 0001104659-26-044892 ↗ |
| 8-K | 2026-04-16 | 2026-04-16 | 0001628280-26-025365 ↗ |
| 8-K | 2026-03-23 | 2026-03-23 | 0001104659-26-033079 ↗ |
| 8-K | 2026-03-09 | 2026-03-09 | 0001104659-26-025240 ↗ |
| 8-K | 2026-02-26 | 2026-02-23 | 0001104659-26-020509 ↗ |
| 8-K | 2026-02-20 | 2026-02-20 | 0001104659-26-018167 ↗ |
| 10-K | 2026-02-20 | 2025-12-31 | 0001628280-26-010185 ↗ |
| 8-K | 2026-01-22 | 2026-01-22 | 0001628280-26-002982 ↗ |
| 8-K | 2025-12-12 | 2025-12-12 | 0001104659-25-120657 ↗ |
| 8-K | 2025-11-21 | 2025-11-18 | 0001104659-25-114995 ↗ |